Probiotix Health PLC Change of Registered Office (5760I)
2022年4月19日 - 5:08PM
RNSを含む英国規制内ニュース (英語)
TIDMPBX
RNS Number : 5760I
Probiotix Health PLC
19 April 2022
ProBiotix Health plc
("ProBiotix Health" or the "Company")
Change of registered office
ProBiotix Health plc (AQSE: PBX), a life sciences business
developing probiotics to tackle cardiovascular disease and other
lifestyle conditions, announces that it has changed its registered
address to: First Floor, Zucchi Suite, Nostell Business Estate,
Wakefield, WF4 1AB with immediate effect.
All formal notices and general correspondence should be sent to
the new address.
For further information, please contact:
Probiotix Health plc Contact via Walbrook below
Stephen O'Hara, Chief Executive
Peterhouse Capital Limited Tel: 020 7469 0930
Mark Anwyl (AQSE Corporate Adviser)
Duncan Vasey (Broker)
Walbrook PR Ltd Mob: 07876 741 001 or probiotix@walbrookpr.com
Anna Dunphy
About ProBiotix Health plc
ProBiotix Health develops probiotics (live microbes that, when
ingested, can alter the composition of the microbiome and improve
human health) to tackle cardiovascular disease and other lifestyle
conditions which are affecting growing numbers of people across the
world.
ProBiotix Health's cholesterol reducing probiotic, Lactobacillus
plantarum ECGC13110402 ("LP-LDL(R)), is manufactured in
pharmaceutical GMP-certified facilities and protected worldwide by
in the region of 5 patent families, comprising 27 patents and
pending patent applications, and 22 trademarks.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NEXGZGMDRLNGZZG
(END) Dow Jones Newswires
April 19, 2022 04:08 ET (08:08 GMT)
Probiotix Health (AQSE:PBX)
過去 株価チャート
から 9 2024 まで 10 2024
Probiotix Health (AQSE:PBX)
過去 株価チャート
から 10 2023 まで 10 2024